Skip to main content
61°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Psychedelic/Assisted Therapies
Recent news which mentions Psychedelic/Assisted Therapies
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
GOP Rep. And Psychedelics Supporter Denounces 'Gerontocracy' At Congressional Level
July 07, 2023
Tags
Psychedelics
Benzinga
Rep/ Matt Gaetz
From
Benzinga
Filament Supplies Botanical Psilocybin To Canadian Researchers, Inks Global Licensing Deal
July 07, 2023
Tickers
FLHLF
Tags
Market News
Cannabis
Markets
From
Benzinga
Can Psychedelics Therapy Be Reimbursed? AMA Releases Details On Coding These Procedures
July 06, 2023
Tickers
CMPS
Tags
MAPS PBC
News
American Medical Association
From
Benzinga
PharmAla's Australian JV Cortexa Orders First Commercial MDMA & Psilocybin Shipment
July 05, 2023
Tickers
PMBHF
Tags
Benzinga
Psychedelics
Australia Psychedelics
From
Benzinga
Small Pharma Implements Costs Cut: New R&D Strategy And Management Team Change
July 05, 2023
Tickers
DMTTF
Tags
Guidance
DMTTF
News
From
Benzinga
Awakn Life Sciences Sells London Clinics Business, Hopes To Divest Norwegian Unit Next
July 05, 2023
Tickers
AWKNF
Tags
AWKNF
Benzinga
Psychedelics
From
Benzinga
80% Of US Voters Support Easing Research Restrictions, Plus Other Insights From UC-Berkeley Poll
July 05, 2023
Tags
Guidance
News
Exclusives
From
Benzinga
Inside UC Berkeley's Nation-Representative Psychedelics Survey: Unveiling Unexpected Data
July 05, 2023
Tags
Market News
Cannabis
Markets
From
Benzinga
COMPASS Pathways Secures Up To $50M In Term Loan Facility With Hercules Capital
July 05, 2023
Tickers
ATAI
CMPS
HTGC
Tags
News
ATAI
HTGC
From
Benzinga
Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More
July 04, 2023
Tickers
BETRF
CYBN
DMTTF
DSNKY
Tags
DMTTF
Guidance
Events
From
Benzinga
Harnessing The Power Of 5-MeO-DMT For Women Trauma Survivors: A Specialized Retreat
July 03, 2023
Tags
Trauma Survivors
News
Top Stories
From
Benzinga
All On Board For 5-MeO-DMT: This Retreat Hosts Expertly Guided Experiences For Women, BIPOC
July 02, 2023
Tags
Top Stories
Exclusives
News
From
Benzinga
Small Pharma Implements Cost-Cutting Strategy To Reduce Cash Burn As Trial Progresses
June 29, 2023
Tickers
DMTTF
Tags
DMT Entities
Psychedelic/Assisted Therapies
Psychedelics
From
Benzinga
Reunion Neuroscience's Q4 And Full Year 2023 Financial Results, To Close Take-Private Deal In Q3
June 29, 2023
Tickers
MSSTF
REUN
Tags
News
Guidance
MSSTF
From
Benzinga
This Biotech Is Entering The Clinical Stage With A Psilocin Analog Targeting Cluster Headaches
June 28, 2023
Tickers
LOBEF
Tags
Markets
Cannabis
Market News
From
Benzinga
BetterLife Fast Tracks Its US Patent For Non-Hallucinogenic Compound And Other LSD Derivatives
June 28, 2023
Tickers
BETRF
PHRRF
Tags
Benzinga
Psychedelics
FDA
From
Benzinga
Cybin's FY2023 Financials, Guidance And Appointment Of Sanford R. Climan As Strategic Advisor
June 28, 2023
Tickers
CYBN
Tags
Benzinga
Psychedelics
Management
From
Benzinga
Ketamine News: PharmaTher Begins FDA Filing For KETARX Application, Stella Acquires Field Trip Assets
June 27, 2023
Tickers
FTHWF
PHRRF
Tags
Microneedle Patch
KETARX
Cannabis
From
Benzinga
Japanese Pharma Company Sponsors Australian Start Up In Development Of Non-Hallucinogenic Medicines
June 27, 2023
Tickers
DSNKY
Tags
Management
Psychedelic/Assisted Therapies
DSNKY
From
Benzinga
UK Greenlights Phase 2 Clinical Trial On Mindset Pharma's Psilocin Drug For Major Depression
June 27, 2023
Tickers
MSSTF
Tags
Legal
Psychedelic/Assisted Therapies
Management
From
Benzinga
MindMed Shareholders Vote For All Six Company Nominees At Annual Meeting, Current R&D Path Upheld
June 27, 2023
Tickers
MNMD
Tags
Penny Stocks
News
Guidance
From
Benzinga
$100M Investment & Donation To Psychedelics Research From Toms Shoes Founder Blake Mycoskie
June 27, 2023
Tags
Blake Mycoskie
News
Psychedelics Financing
From
Benzinga
MDMA Deals: Optimi Supplies Numinus-MAPS Program & PharmAla Exports To Australian University
June 20, 2023
Tickers
NUMIF
OPTHF
PMBHF
Tags
News
NUMIF
Markets
From
Benzinga
Johns Hopkins Researchers Find Psychedelics Reopen The Social Reward Learning Period
June 19, 2023
Tags
News
Benzinga
Psychedelics
From
Benzinga
CNN Goes Psychedelic: Anderson Cooper's Upcoming Show On Magic Mushrooms
June 16, 2023
Tickers
NFLX
Tags
Markets
Market News
Cannabis
From
Benzinga
Awakn Life Sciences Announces Closing Of Second Tranche And Upsizing Of Previous Private Placement
June 15, 2023
Tickers
AWKNF
Tags
Financing
Psychedelic/Assisted Therapies
AWKNF
From
Benzinga
Nevada Governor Passes Psychedelics Bill To Form New Working Group And Future Regulated Access
June 15, 2023
Tags
News
Benzinga
Psychedelics
From
Benzinga
Federal Psychedelics: $75M Grant Program, NIDA's Special Interest In State & Local Reform
June 14, 2023
Tags
Government
NIDA/funded trial
Psychedelics
From
Benzinga
Canadian Financing: PharmAla Biotech Offers Non-Brokered Private Placement Up To $3.76M
June 13, 2023
Tickers
PMBHF
Tags
Contracts
Next/Generation Psychedelics
Markets
From
Benzinga
Silo Pharma's New Ketamine Implant For Fibromyalgia And Chronic Pain Is In The Making
June 13, 2023
Tickers
SILO
TRYPF
Tags
Psychedelic/Assisted Therapies
Markets
fibromyalgia
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.